Skip to content

David Daniel Davila, D.O.

NPI 1063422582ActiveIndividual· Surgery· Houston, TX

Surgery (D.O.) in Houston, Texas, licensed in TX and OK, with an NPI issued in August 2006. Part D covered 24 prescriptions written in 2024, 100% of them generic. Galderma Laboratories, L.P. reported $39.84 in payments in 2025, mostly food and beverage.

Overview

NPI1063422582
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorYes
NPI issuedAug 8, 2006
Last updated in NPPESNov 20, 2018

Specialties and licenses

TaxonomyCodeLicenseState
Surgery Primary208600000XL9166TX
Surgery208600000X3715OK

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)24 · 26 30-day fills
Total drug cost$152.88
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$39.84 · 2 payments from 1 company
  • 2024$370.53 · 10 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Galderma Laboratories, L.P.$39.842

What the 2025 payments were for

  • Food and Beverage$39.84 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery providers in Houston

All Surgery providers in Texas →